BR0113055A - Preparação sólida altamente absorvìvel - Google Patents

Preparação sólida altamente absorvìvel

Info

Publication number
BR0113055A
BR0113055A BR0113055-2A BR0113055A BR0113055A BR 0113055 A BR0113055 A BR 0113055A BR 0113055 A BR0113055 A BR 0113055A BR 0113055 A BR0113055 A BR 0113055A
Authority
BR
Brazil
Prior art keywords
solid preparation
highly absorbable
ability
absorbable solid
absorbed
Prior art date
Application number
BR0113055-2A
Other languages
English (en)
Inventor
Katsuo Kataoka
Hiroshi Kikuchi
Tatsuya Suzuki
Takahiro Shimaya
Hideo Kobayashi
Akira Kurosawa
Koichi Ishido
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of BR0113055A publication Critical patent/BR0113055A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PREPARAçãO SóLIDA ALTAMENTE ABSORVìVEL". Uma preparação sólida contendo como o ingrediente ativo um grande volume de um composto quinolona fracamente solúvel em água em pH em torno da neutralidade, particularmente a sitafloxacina, que é melhorado quanto à capacidade de ser absorvida por via oral e de difusão da capacidade de ser absorvida mediante a adição de um ácido orgânico, particularmente o ácido tartárico.
BR0113055-2A 2000-08-08 2001-08-07 Preparação sólida altamente absorvìvel BR0113055A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000239233 2000-08-08
PCT/JP2001/006776 WO2002011726A1 (fr) 2000-08-08 2001-08-07 Preparation solide hautement absorbable

Publications (1)

Publication Number Publication Date
BR0113055A true BR0113055A (pt) 2003-07-08

Family

ID=18730805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113055-2A BR0113055A (pt) 2000-08-08 2001-08-07 Preparação sólida altamente absorvìvel

Country Status (14)

Country Link
US (2) US6861071B2 (pt)
EP (1) EP1308160A4 (pt)
JP (1) JP3573287B2 (pt)
KR (1) KR100878667B1 (pt)
CN (1) CN1214792C (pt)
AR (1) AR030128A1 (pt)
AU (1) AU2001276748A1 (pt)
BR (1) BR0113055A (pt)
CA (1) CA2417764C (pt)
MX (1) MXPA03001206A (pt)
NO (1) NO323835B1 (pt)
RU (1) RU2287328C2 (pt)
TW (1) TWI278316B (pt)
WO (1) WO2002011726A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1854463A4 (en) * 2005-03-03 2011-03-23 Takeda Pharmaceutical COMPOSITION WITH CONTROLLED RELEASE
CN113777180B (zh) * 2020-08-12 2023-05-02 济川药业集团有限公司 一种同时检测西他沙星及其多种异构体杂质的方法
CN113181125B (zh) * 2021-04-27 2022-07-19 海南通用三洋药业有限公司 一种西他沙星片剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
CA2085871C (en) * 1991-12-27 2002-05-07 Gerald S. Rork A controlled release drug dispersion delivery device
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
DK0688772T3 (da) * 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
AU692583B2 (en) * 1994-08-12 1998-06-11 Toyama Chemical Co. Ltd. Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
US6057323A (en) * 1996-03-08 2000-05-02 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) * 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US6709678B2 (en) * 1996-08-15 2004-03-23 Losan Pharma Gmbh Easy to swallow oral medicament composition
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
WO1998058928A1 (fr) * 1997-06-23 1998-12-30 Yoshitomi Pharmaceutical Industries, Ltd. Agent prophylactique ou therapeutique contre des maladies attribuables a une infection par des helicobacters
AUPO758297A0 (en) * 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
JP4299385B2 (ja) * 1997-07-15 2009-07-22 富山化学工業株式会社 パズフロキサシン細粒剤
JP4299384B2 (ja) * 1997-07-15 2009-07-22 富山化学工業株式会社 溶出遅延防止細粒剤
IN186245B (pt) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CZ2001901A3 (cs) * 1998-09-14 2001-08-15 Ranbaxy Laboratories Limited Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu

Also Published As

Publication number Publication date
CA2417764A1 (en) 2002-02-14
RU2287328C2 (ru) 2006-11-20
KR20030040348A (ko) 2003-05-22
NO20030626D0 (no) 2003-02-07
NO323835B1 (no) 2007-07-09
KR100878667B1 (ko) 2009-01-13
AU2001276748A1 (en) 2002-02-18
US20030176452A1 (en) 2003-09-18
WO2002011726A1 (fr) 2002-02-14
EP1308160A4 (en) 2005-01-19
EP1308160A1 (en) 2003-05-07
JP3573287B2 (ja) 2004-10-06
NO20030626L (no) 2003-02-07
CA2417764C (en) 2009-05-05
TWI278316B (en) 2007-04-11
CN1444480A (zh) 2003-09-24
MXPA03001206A (es) 2003-06-30
CN1214792C (zh) 2005-08-17
AR030128A1 (es) 2003-08-13
US20040132756A1 (en) 2004-07-08
US6861071B2 (en) 2005-03-01

Similar Documents

Publication Publication Date Title
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
HN2002000247A (es) Derivados de sulfonamida
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
GB0022438D0 (en) Organic Compounds
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
WO2002022598A8 (en) Quinolinone derivatives as tyrosine kinase inhibitors
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
DK1526839T3 (da) Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
SE0102440D0 (sv) New compound
DK1414467T3 (da) Topisk behandling af mastalgi
DE602005025339D1 (de) Flavonoide und Tocotrienole enthaltende Zusammensetzungen und deren Verwendungen
DE60112781D1 (de) Stabile orale zusammensetzung enthaltend benzimidazol derivate
DE60025503D1 (de) Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten
DE60117523D1 (de) Orale zubereitung chlorhexidin und maltitol oder erythritol oder deren mischung enthaltend
BR0113055A (pt) Preparação sólida altamente absorvìvel
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
SE0001916D0 (sv) Novel formulation
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
AU2003256108A1 (en) Organic acid salt of amlodipine

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.